Analyst Consensus ?
ConsensusHold25 ratings
Bullish1144.0%
Neutral1352.0%
Bearish14.0%
FN2 Earnings Intelligence
Trane Technologies plc complete analyst coverage
Trane Technologies plc (TT) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$470.03Current
$155Low
$362.43Average
$585High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | May 14, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 1, 2026 |
| Keybanc | Overweight | Overweight | Maintain | May 1, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 1, 2026 |
| Citigroup | Buy | Buy | Maintain | May 1, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 1, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jan 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 13, 2026 |
| UBS | Buy | Buy | Maintain | Jan 5, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Nov 13, 2025 |
| HSBC | Hold | Buy | Downgrade | Jul 31, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 8, 2025 |
| Melius Research | Hold | Buy | Downgrade | Jan 28, 2025 |
| Mizuho | Neutral | Neutral | Maintain | Oct 17, 2024 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Aug 5, 2024 |
| TD Cowen | Buy | Buy | Maintain | May 1, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 12, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 3, 2022 |
| Jefferies | Hold | Hold | Maintain | Jul 15, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jul 8, 2022 |
| Wolfe Research | Peer Perform | Peer Perform | Maintain | Feb 1, 2022 |
| Vertical Research | Hold | Buy | Downgrade | Jan 3, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $470.03. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $555 | $471.95 | +18.1% | Jul 9, 2026 |
| Bernstein | Analyst unavailable | $550 | $470.76 | +17.0% | Jun 9, 2026 |
| Morgan Stanley | Christopher Snyder | $565 | $484.6 | +20.2% | May 4, 2026 |
| Oppenheimer | Noah Kaye | $530 | $495.64 | +12.8% | May 1, 2026 |
| Mizuho Securities | Brett Linzey | $475 | $495.3 | +1.1% | May 1, 2026 |
| Evercore ISI | Analyst unavailable | $560 | $495.82 | +19.1% | May 1, 2026 |
| KeyBanc | Analyst unavailable | $555 | $492.54 | +18.1% | May 1, 2026 |
| Barclays | Julian Mitchell | $585 | $492.54 | +24.5% | May 1, 2026 |
| KeyBanc | Analyst unavailable | $525 | $477.24 | +11.7% | Apr 21, 2026 |
| BNP Paribas | Andrew Buscaglia | $550 | $472.94 | +17.0% | Apr 14, 2026 |
| Oppenheimer | Noah Kaye | $468 | $426.07 | -0.4% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $450 | $426.07 | -4.3% | Jan 30, 2026 |
| RBC Capital | Deane Dray | $470 | $426.07 | -0.0% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $507 | $426.07 | +7.9% | Jan 30, 2026 |
| Oppenheimer | Noah Kaye | $460 | $389.53 | -2.1% | Jan 20, 2026 |
| Robert W. Baird | Analyst unavailable | $445 | $381.7 | -5.3% | Jan 12, 2026 |
| Melius Research | Scott Davis | $490 | $381.1 | +4.2% | Jan 7, 2026 |
| Barclays | Julian Mitchell | $505 | $381.1 | +7.4% | Jan 7, 2026 |
| UBS | Analyst unavailable | $520 | $399.28 | +10.6% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $370 | $398 | -21.3% | Jan 5, 2026 |
| KeyBanc | Analyst unavailable | $500 | $390.84 | +6.4% | Dec 15, 2025 |
| Barclays | Julian Mitchell | $506 | $409.07 | +7.7% | Dec 4, 2025 |
| Robert W. Baird | Analyst unavailable | $500 | $449.42 | +6.4% | Oct 31, 2025 |
| Barclays | Julian Mitchell | $485 | $401.28 | +3.2% | Sep 16, 2025 |
| Stephens | Analyst unavailable | $500 | $433.97 | +6.4% | Aug 4, 2025 |
| HSBC | Wesley Brooks | $460 | $431.44 | -2.1% | Jul 30, 2025 |
| Barclays | Analyst unavailable | $475 | $344.65 | +1.1% | Mar 10, 2025 |
| Wells Fargo | Joseph O'Dea | $380 | $379.96 | -19.2% | Jan 7, 2025 |
| HSBC | Wesley Brooks | $405 | $375.52 | -13.8% | Oct 31, 2024 |
| Stephens | Tommy Moll | $425 | $397.5 | -9.6% | Oct 16, 2024 |
| Robert W. Baird | Timothy Wojs | $408 | $399.86 | -13.2% | Oct 14, 2024 |
| Morgan Stanley | Chris Snyder | $425 | $342.91 | -9.6% | Sep 6, 2024 |
| RBC Capital | Deane Dray | $350 | $334.28 | -25.5% | Aug 1, 2024 |
| Barclays | Julian Mitchell | $380 | $321.5 | -19.2% | Jun 4, 2024 |
| Stephens | Tommy Moll | $320 | $317.34 | -31.9% | May 1, 2024 |
| Mizuho Securities | Brett Linzey | $325 | $312.71 | -30.9% | May 1, 2024 |
| RBC Capital | Deane Dray | $330 | $313.64 | -29.8% | May 1, 2024 |
| Barclays | Julian Mitchell | $354 | $317.34 | -24.7% | May 1, 2024 |
| Goldman Sachs | Analyst unavailable | $203 | $185.73 | -56.8% | Feb 6, 2023 |
| Stephens | Analyst unavailable | $185 | $185.12 | -60.6% | Feb 6, 2023 |
| RBC Capital | Analyst unavailable | $177 | $185.39 | -62.3% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $176 | $185.14 | -62.6% | Feb 3, 2023 |
| Citigroup | Analyst unavailable | $218 | $187.08 | -53.6% | Feb 3, 2023 |
| BMO Capital | John Joyner | $180 | $168.75 | -61.7% | Dec 20, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $155 | $138.44 | -67.0% | Jun 6, 2022 |
| Deutsche Bank | Nicole Deblase | $184 | $167.18 | -60.9% | Feb 1, 2022 |
| Jefferies | Stephen Volkmann | $195 | $175.49 | -58.5% | Jan 24, 2022 |
| Vertical Research | Jeffrey Sprague | $214 | $194.01 | -54.5% | Jan 3, 2022 |
| UBS | Markus Mittermaier | $206 | $198.94 | -56.2% | Dec 14, 2021 |
| Stephens | Tommy Moll | $205 | $179.55 | -56.4% | Nov 4, 2021 |
| BMO Capital | Joel Tiss | $210 | $179.55 | -55.3% | Nov 4, 2021 |
| Robert W. Baird | Timothy Wojs | $200 | $177 | -57.4% | Nov 3, 2021 |
| Cowen & Co. | Gautam Khanna | $200 | $195.81 | -57.4% | Sep 1, 2021 |
| J.P. Morgan | Stephen Tusa | $160 | $191.87 | -66.0% | Aug 9, 2021 |
| Argus Research | John Eade | $220 | $193.39 | -53.2% | Aug 5, 2021 |
| Bank of America Securities | Andrew Obin | $207 | $199.35 | -56.0% | Jul 23, 2021 |
Track every rating change on TT the moment it posts. Free to start.
Start free